These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
991 related items for PubMed ID: 24591332
1. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A. Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332 [Abstract] [Full Text] [Related]
2. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A. Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798 [Abstract] [Full Text] [Related]
3. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M. Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578 [Abstract] [Full Text] [Related]
4. Renal denervation in moderate treatment-resistant hypertension. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901 [Abstract] [Full Text] [Related]
5. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F. Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557 [Abstract] [Full Text] [Related]
6. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M. Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238 [Abstract] [Full Text] [Related]
7. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY Investigators. Hypertension; 2017 Apr 30; 69(4):678-684. PubMed ID: 28264922 [Abstract] [Full Text] [Related]
8. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels. Lambert T, Nahler A, Reiter C, Gammer V, Blessberger H, Kammler J, Grund M, Saleh K, Schwarz S, Steinwender C. Catheter Cardiovasc Interv; 2015 Sep 30; 86(3):E126-30. PubMed ID: 26033366 [Abstract] [Full Text] [Related]
9. The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up. Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM. Blood Press; 2021 Feb 30; 30(1):41-50. PubMed ID: 33030064 [Abstract] [Full Text] [Related]
10. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H. Catheter Cardiovasc Interv; 2013 Feb 30; 81(2):335-9. PubMed ID: 22807098 [Abstract] [Full Text] [Related]
12. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. Oliveras A, Armario P, Clarà A, Sans-Atxer L, Vázquez S, Pascual J, De la Sierra A. J Hypertens; 2016 Sep 30; 34(9):1863-71. PubMed ID: 27327441 [Abstract] [Full Text] [Related]
18. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study. Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S. Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375 [Abstract] [Full Text] [Related]
19. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium. Blood Press; 2015 Feb 01; 24(5):263-74. PubMed ID: 26194721 [Abstract] [Full Text] [Related]
20. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A. Kardiol Pol; 2016 Feb 01; 74(9):961-8. PubMed ID: 27160171 [Abstract] [Full Text] [Related] Page: [Next] [New Search]